Zeposia 0.23 mg

Zeposia 0.23 mg is a medicine authorised by Swissmedic under authorisation number 67046. The authorisation holder is Bristol-Myers Squibb SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 11 August 2020 and the authorisation is valid without a time limit. ATC code L04AE02 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 67046
  • ATC L04AE02
  • Synthetic medicines
Authorisation data
Authorisation number67046
NameZeposia 0.23 mg
Full nameZeposia 0.23 mg, Hartkapseln
Authorisation holderBristol-Myers Squibb SA
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeL04AE02
First authorisation11 August 2020
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Zeposia 0.23 mg, HartkapselnB11 August 2020
2Zeposia 0.46 mg, HartkapselnB11 August 2020
3Zeposia 0.92 mg, HartkapselnB11 August 2020

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Kombipackung(en)L04AE0201.99.0.B
31Kombipackung(en)L04AE0201.99.0.B
228Kapsel(n)L04AE0201.99.0.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Zeposia 0.23 mg authorised in Switzerland?

Yes. Zeposia 0.23 mg is authorised by Swissmedic under authorisation number 67046, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Zeposia 0.23 mg have?

Zeposia 0.23 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Zeposia 0.23 mg?

The authorisation holder is Bristol-Myers Squibb SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com